Ulipristal Acetate (UPA)

Benefits of self-administered DMPA injections, an analysis of prophylactic pain management in medication abortion care, a need for ongoing education for providers on clinical indications for pelvic exams, the potential use of mifepristone as emergency contraception, and more.

Guidance for providers on medication abortion provision up to 70 days gestation, the need for expanded access to the most effective forms of emergency contraception, the important role partner treatment can play in the treatment of bacterial vaginosis, and more.

Society of Family Planning’s clinical recommendations for contraceptive counseling for transgender and gender-expansive patients, the positive effect of levonorgestrel IUDs on female sexual function, barriers to abortion care within religious hospital systems, and more.

What you need to know about the current research and how to talk to patients.

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

Barriers to accessing EC pills exist, what are they and how can you help people get the EC pills they need.

Here’s what you need to know to help your patients balance risks and uncertainties related to starting hormonal birth control after ella.

Do you know what info your patients are getting about EC?